Camelot Portfolios, LLC Bristol Myers Squibb CO Transaction History

Camelot Portfolios, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$40.25 - $52.99 $22,540 - $29,674	560 New	560 $23,000
Q1 2020 Apr 28, 2020	SELL	$46.4 - $67.43 $652,244 - $947,863	-14,057 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$49.21 - $64.19 $7,086 - $9,243	144 Added 1.04%	14,057 $902,000
Q3 2019 Oct 15, 2019	SELL	$42.77 - $50.71 $44,780 - $53,093	-1,047 Reduced 7.0%	13,913 $706,000
Q2 2019 Jul 19, 2019	BUY	$44.62 - $49.34 $9,905 - $10,953	222 Added 1.51%	14,960 $678,000
Q1 2019 Apr 25, 2019	BUY	$45.12 - $53.8 $664,978 - $792,904	14,738 New	14,738 $703,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

Stay updated on Camelot Portfolios, LLC with notifications on news.